Pseudohypoparathyroidism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:97593E20.1
Who is this for?
Show terms as
1Active trials11Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
May 2020Theophylline for Treatment of Pseudohypoparathyroidism

Ashley Shoemaker — PHASE2

TrialENROLLING BY INVITATION

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Pseudohypoparathyroidism.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Phase 21 trial
Theophylline for Treatment of Pseudohypoparathyroidism
Phase 2
Enrolling by Invitation
PI: Ashley Shoemaker, MD (Vanderbilt University Medical Center) · Sites: Nashville, Tennessee · Age: 299 yrs

Specialists

11 foundView all specialists →
AM
Ashley Shoemaker, MD
Nashville, Tennessee
Specialist

Rare Disease Specialist

PI on 4 active trials
TP
Tanja T Sikjær, MD, PhD
Specialist
PI on 1 active trial
LP
Lars Rejnmark, DmSci, PhD
Specialist
PI on 2 active trials
MG
Mitchell E. Geffner
LOS ANGELES, CA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
⚗️ Trial Site

Vanderbilt University Medical Center

📍 Nashville, Tennessee

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

Travel Grants

No travel grants are currently matched to Pseudohypoparathyroidism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open PseudohypoparathyroidismForum →

No community posts yet. Be the first to share your experience with Pseudohypoparathyroidism.

Start the conversation →

Latest news about Pseudohypoparathyroidism

Disease timeline:

New trial: Theophylline for Treatment of Pseudohypoparathyroidism

Phase PHASE2 trial recruiting. Theophylline ER

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pseudohypoparathyroidism

Are there clinical trials for Pseudohypoparathyroidism?

Yes — 1 recruiting clinical trial is currently listed for Pseudohypoparathyroidism on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Pseudohypoparathyroidism?

11 specialists and care centers treating Pseudohypoparathyroidism are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.